The influence of baseline characteristics, treatment and depression on health-related quality of life in patients with multiple myeloma: a prospective observational study
Abstract Background Multiple myeloma (MM) is the third most common hematologic malignancy with increasing importance due to improving treatment strategies and long-term outcomes in an aging population. This study aims to analyse influencing factors on health-related quality of life (HRQoL), such as...
Main Authors: | Julia Fischer, Stefan Knop, Sophia Danhof, Hermann Einsele, Daniela Keller, Claudia Löffler |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-022-10101-9 |
Similar Items
-
Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma
by: Xiang Zhou, et al.
Published: (2020-07-01) -
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network
by: Elisabetta Antonioli, et al.
Published: (2023-04-01) -
Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease
by: Xiang Zhou, et al.
Published: (2020-04-01) -
Challenges in designing and running smouldering myeloma interventional clinical trials
by: Catherine Lecat, et al.
Published: (2024-04-01) -
Level of depression and occurrence of cognitive changes in patients with multiple myeloma - a preliminary report
by: Magdalena Bury-Kamińska, et al.
Published: (2022-07-01)